LSC Webinars CELL All

  1. Optimal Tech For Predicting Drug Responses At The Cellular Level 4/1/2025

    Explore how preserving spatial molecular information and leveraging AI-driven spatial-omics can transform treatment prediction, patient stratification, and personalized medicine.

  2. Driving Innovation In Decentralized Manufacturing 3/27/2025

    Unlock the potential of localized manufacturing and see how cutting-edge technology is transforming access to essential medications, ensuring patients get what they need.

  3. Clinical-Grade Manufacturing Of Difficult-To-Transduce Cells 3/20/2025

    Discover how Miltenyi R&D and Bioindustry experts revolutionize cellular therapy with BaEV-env LVVs as well as gain insights into preclinical evaluations and clinical-grade product development for CAR-NK cells.

  4. Tools For Efficient Downstream Processing Of Antibody-Based Therapeutics 3/20/2025

    Watch and discover how to effectively utilize chromatography tools for improved purification of therapeutic monoclonal antibodies and antibody derivatives.

  5. Who's In Charge? How To Ensure Effective Trial Oversight, Leadership 3/19/2025

    Gain valuable insights into the role of sponsor-side Clinical Operations leadership, the risks of over-relying on CROs, and key strategies for fostering collaboration between sponsors and partners.

  6. Human Factors Testing: Engaging End-Users In Med Device Development 3/11/2025

    Explore the significance of human factors in the development of medical devices through an illustration of how important it is to incorporate the end users in the device development process.

  7. Discovery Through Commercialization: A Biologic Drug's Analytical Journey 3/4/2025

    Gain valuable insights into advanced methods and analysis techniques for high-order structure, physiochemical characterization, cell-based and biochemical assays, and more.

  8. From Research To Reality: Overcoming CMC Challenges In Cell & Gene Therapy 2/20/2025

    Explore the importance of adopting a Quality by Design (QbD) approach in the development process while integrating regulatory and CMC strategies for maximum efficiency and benefit.

  9. Efficient Downstream Processing Of Antibody-Based Therapeutics – A CDMO Perspective 2/18/2025

    Discover efficient downstream processing strategies for antibody-based therapeutics. Explore key considerations and trade-offs in purity, yield, speed, and cost, from a CDMO perspective.

  10. The Next Frontier In mRNA: Modular Manufacturing For Scalable RNA-LNP Therapies 1/29/2025

    Explore constructing a modular RNA-LNP GMP facility using Cytiva's FlexFactory™ process train in a KUBio™ environment to scale RNA-LNP therapies.